|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.98 EUR | +0.63% |
|
-1.96% | -3.85% |
| Dec. 13 | Eutelsat: delisted from the SBF 120 and CAC Mid 60 indices | CF |
| Dec. 13 | Euroapi: delisted from the SBF 120 and CAC Mid 60 indices | CF |
| Capitalization | 467M 491M 444M 393M 704M 42.33B 777M 5.36B 1.97B 17.52B 1.84B 1.8B 76.45B | P/E ratio 2025 * |
-24.6x | P/E ratio 2026 * | 38x |
|---|---|---|---|---|---|
| Enterprise value | 515M 542M 490M 434M 776M 46.68B 857M 5.91B 2.17B 19.33B 2.03B 1.99B 84.32B | EV / Sales 2025 * |
23.7x | EV / Sales 2026 * | 12.8x |
| Free-Float |
61.66% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: MedinCell S.A.
| Medincell: Publication of the 2025 Financial Calendar | Jan. 15 | BU |
| Medincell to Join the Euronext SBF 120 Index | Dec. 12 | BU |
| Medincell to Join the Euronext SBF 120 Index | Dec. 12 | BU |
| MedinCell S A : Half-Year Report | Dec. 10 | PU |
| MedinCell S A : Consolidated Half-Year Financial Results | Dec. 10 | PU |
More news
| 1 day | +0.63% | ||
| 1 week | -1.96% | ||
| Current month | -3.85% | ||
| 1 month | -4.65% | ||
| 3 months | +6.53% | ||
| 6 months | +0.25% | ||
| Current year | -3.85% |
1 week
15.62
17.60
1 month
15.6218.64
Current year
15.6218.64
1 year
8.0819.00
3 years
4.7319.00
5 years
4.3520.00
10 years
4.3520.00
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 61 | 2003-01-08 |
Stéphane Postic
DFI | Director of Finance/CFO | 51 | 2023-08-31 |
Richard Malamut
CTO | Chief Tech/Sci/R&D Officer | 65 | 2022-05-08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sabri Markabi
CHM | Chairman | - | 2024-02-14 |
Philippe Guy
CHM | Chairman | - | 2024-03-12 |
Virginie Lleu
BRD | Director/Board Member | - | 2016-05-24 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.63% | -1.96% | +94.88% | +93.70% | 491M | ||
| +2.45% | +8.22% | +23.94% | +226.68% | 707B | ||
| +7.13% | +8.13% | -14.15% | +104.43% | 389B | ||
| +0.12% | -0.14% | -7.64% | -9.91% | 353B | ||
| -0.22% | -0.73% | +3.70% | +28.86% | 301B | ||
| -1.12% | -2.42% | -19.62% | +21.21% | 242B | ||
| +0.18% | +3.58% | +12.14% | -20.26% | 244B | ||
| +0.04% | +1.02% | +5.70% | +32.88% | 214B | ||
| 0.00% | +1.05% | -3.50% | +17.60% | 199B | ||
| +0.31% | -0.80% | -7.91% | -49.38% | 148B | ||
| Average | +0.74% | +1.53% | +8.75% | +44.58% | 279.87B | |
| Weighted average by Cap. | +0.97% | +3.25% | +2.66% | +74.90% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 21.71M 22.82M 20.65M 18.27M 32.71M 1.97B 36.1M 249M 91.45M 814M 85.52M 83.83M 3.55B | 39.26M 41.28M 37.35M 33.05M 59.15M 3.56B 65.29M 450M 165M 1.47B 155M 152M 6.43B |
| Net income | -16.09M -16.92M -15.31M -13.54M -24.24M -1.46B -26.76M -185M -67.78M -604M -63.39M -62.14M -2.63B | 9.97M 10.48M 9.48M 8.39M 15.02M 903M 16.57M 114M 41.99M 374M 39.27M 38.49M 1.63B |
| Net Debt | 48.05M 50.52M 45.71M 40.45M 72.4M 4.35B 79.9M 551M 202M 1.8B 189M 186M 7.86B | 36.7M 38.59M 34.91M 30.9M 55.3M 3.33B 61.03M 421M 155M 1.38B 145M 142M 6.01B |
More financial data
* Estimated data
Employees
131
Sector
Pharmaceuticals
Calendar
2025-06-16
- Q4 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-24 | 15.98 € | +0.63% | 30,737 |
| 25-01-23 | 15.88 € | -1.24% | 47,176 |
| 25-01-22 | 16.08 € | +0.75% | 57,723 |
| 25-01-21 | 15.96 € | -1.60% | 126,075 |
| 25-01-20 | 16.22 € | -0.49% | 20,967 |
Real-time Euronext Paris, January 24, 2025 at 11:35 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
15.98EUR
Average target price
23.17EUR
Spread / Average Target
+44.97%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDCL Stock